Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ: REGN · Real-Time Price · USD

634.07

-26.93 (-4.07%)

At close: Mar 25, 2025, 4:00 PM

633.03

-1.04 (-0.16%)

After-hours: Mar 25, 2025, 5:39 PM EST

Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of $67.87 billion as of March 25, 2025. Its market cap has decreased by -36.47% in one year.

Market Cap

67.87B

Enterprise Value

52.89B

1-Year Change

-36.47%

Ranking

#199

Market Cap Chart

Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $67.87B, an increase of 26,832.00%. That is a compound annual growth rate of 23.68%.

Market Cap History

Date	Market Cap	% Change
Mar 24, 2025	72.26B	-7.68%
Dec 31, 2024	78.28B	-18.19%
Dec 29, 2023	95.69B	21.78%
Dec 30, 2022	78.57B	15.69%
Dec 31, 2021	67.92B	31.74%
Dec 31, 2020	51.55B	25.04%
Dec 31, 2019	41.23B	1.98%
Dec 31, 2018	40.43B	0.08%
Dec 29, 2017	40.39B	4.33%
Dec 30, 2016	38.72B	-31.47%
Dec 31, 2015	56.49B	35.45%
Dec 31, 2014	41.71B	52.42%
Dec 31, 2013	27.36B	65.66%
Dec 31, 2012	16.52B	221.91%
Dec 30, 2011	5.13B	89.94%
Dec 31, 2010	2.70B	38.80%
Dec 31, 2009	1.95B	33.11%
Dec 31, 2008	1.46B	-8.46%
Dec 31, 2007	1.60B	38.55%
Dec 29, 2006	1.15B	29.12%
Dec 30, 2005	893.00M	73.94%
Dec 31, 2004	513.40M	-36.89%
Dec 31, 2003	813.50M	-0.20%
Dec 31, 2002	815.10M	-33.81%
Dec 31, 2001	1.23B	-5.01%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	765.04B
UnitedHealth Group	469.66B
Johnson & Johnson	388.08B
AbbVie	356.11B
Novo Nordisk	335.17B
AstraZeneca	227.33B
Merck & Co.	221.91B
Abbott Laboratories	217.87B

Market Cap Rankings